Received Apr 28, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5549J | — |
administered the prefilled syringe of sterile water diluent component without the single-dose vial of lyophilized antigen component; administered the prefilled syringe of sterile water diluent component without the single-dose vial of lyophilized antigen component; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received MMR (Priorix) (batch number 5549J, expiry date 01-APR-2027) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: administered the prefilled syringe of sterile water diluent component without the single-dose vial of lyophilized antigen component) and inappropriate dose of vaccine administered (Verbatim: administered the prefilled syringe of sterile water diluent component without the single-dose vial of lyophilized antigen component). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.